0001708138-20-000029.txt : 20200403
0001708138-20-000029.hdr.sgml : 20200403
20200403164934
ACCESSION NUMBER: 0001708138-20-000029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200401
FILED AS OF DATE: 20200403
DATE AS OF CHANGE: 20200403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Landry Robert E
CENTRAL INDEX KEY: 0001585160
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 20774167
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-04-01
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001585160
Landry Robert E
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP Finance CFO
Common Stock
2020-04-01
4
S
0
23
478.97
D
24950
D
Common Stock
2020-04-01
4
S
0
75
479.5
D
24875
D
Common Stock
2020-04-01
4
S
0
87
481.91
D
24788
D
Common Stock
2020-04-01
4
S
0
1
484.14
D
24787
D
Common Stock
2020-04-01
4
S
0
23
486.27
D
24764
D
Common Stock
2020-04-01
4
S
0
23
488.77
D
24741
D
Common Stock
2020-04-01
4
S
0
61
489.46
D
24680
D
Common Stock
2020-04-01
4
S
0
87
490.7
D
24593
D
Common Stock
2020-04-01
4
S
0
64
492.61
D
24529
D
Common Stock
2020-04-01
4
S
0
156
493.08
D
24373
D
Common Stock
2020-04-01
4
M
0
2500
272.7
A
26873
D
Common Stock
2020-04-01
4
F
0
1936
488.22
D
24937
D
Common Stock
2020-04-01
4
M
0
2000
272.7
A
26937
D
Common Stock
2020-04-01
4
F
0
1549
488.22
D
25388
D
Common Stock
2020-04-01
4
M
0
1500
272.7
A
26888
D
Common Stock
2020-04-01
4
F
0
1162
488.2
D
25726
D
Common Stock
2020-04-02
4
M
0
3000
272.7
A
28726
D
Common Stock
2020-04-02
4
F
0
2317
492.05
D
26409
D
Common Stock
2020-04-02
4
S
0
139
483.51
D
26270
D
Common Stock
2020-04-02
4
S
0
22
484.96
D
26248
D
Common Stock
2020-04-02
4
S
0
62
485.63
D
26186
D
Common Stock
2020-04-02
4
S
0
78
486.66
D
26108
D
Common Stock
2020-04-02
4
S
0
91
487.29
D
26017
D
Common Stock
2020-04-02
4
S
0
246
488.55
D
25771
D
Common Stock
2020-04-02
4
S
0
128
489.39
D
25643
D
Common Stock
2020-04-02
4
S
0
51
490.11
D
25592
D
Common Stock
2020-04-02
4
S
0
85
491.72
D
25507
D
Common Stock
2020-04-02
4
S
0
109
492.6
D
25398
D
Common Stock
2020-04-02
4
S
0
146
493.54
D
25252
D
Common Stock
2020-04-02
4
S
0
91
494.68
D
25161
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 75 shares of Company stock on April 1, 2020 at prices ranging from $479.06 to $479.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 87 shares of Company stock on April 1, 2020 at prices ranging from $481.85 to $481.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 61 shares of Company stock on April 1, 2020 at prices ranging from $489.44 to $489.48. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 87 shares of Company stock on April 1, 2020 at prices ranging from $490.41 to $490.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 64 shares of Company stock on April 1, 2020 at prices ranging from $492.07 to $492.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 156 shares of Company stock on April 1, 2020 at prices ranging from $493.00 to $493.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
Represents volume-weighted average price of sales of 139 shares of Company stock on April 2, 2020 at prices ranging from $483.28 to $483.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 62 shares of Company stock on April 2, 2020 at prices ranging from $485.01 to $485.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 78 shares of Company stock on April 2, 2020 at prices ranging from $486.62 to $486.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 91 shares of Company stock on April 2, 2020 at prices ranging from $487.04 to $487.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 246 shares of Company stock on April 2, 2020 at prices ranging from $488.02 to $488.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 128 shares of Company stock on April 2, 2020 at prices ranging from $489.07 to $489.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 85 shares of Company stock on April 2, 2020 at prices ranging from $491.64 to $491.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 109 shares of Company stock on April 2, 2020 at prices ranging from $492.37 to $492.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 146 shares of Company stock on April 2, 2020 at prices ranging from $493.01 to $493.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Represents volume-weighted average price of sales of 91 shares of Company stock on April 2, 2020 at prices ranging from $494.00 to $494.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
Form one of two
/s/**Robert E. Landry
2020-04-03